Turn Therapeutics Inc. (TTRX) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Turn Therapeutics Inc. on August 18, 2026, covering events occurring on August 13, 2026. The Company is a Delaware corporation with its principal executive offices in Westlake Village, California, and its common stock trades on The Nasdaq Stock Market LLC under the symbol "TTRX". The Company is classified as an emerging growth company.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity metrics. The report focuses exclusively on a specific corporate transaction regarding equity securities.
Material Changes
The primary material event reported is the full exercise of a warrant by GEM Yield Bahamas Limited ("GEM"). Key details include:
- Warrant Origin: Issued on October 8, 2025, to purchase 1,192,207 shares of Common Stock (representing 4% of fully diluted shares at issuance).
- Exercise Price: $5.03 per share.
- Exercise Method: GEM exercised the warrant in full on August 13, 2026, utilizing the "Cashless Exercise Provision" because the Per Share Market Value exceeded the Warrant Price.
- Shares Issued: The Company issued 579,664 shares of Common Stock to GEM as a result of the cashless exercise.
- Regulatory Basis: The issuance relied on the Section 4(a)(2) exemption from registration under the Securities Act of 1933, based on GEM's status as an accredited investor.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the standard disclosure of the unregistered sale of equity securities.
Investor Verification Checklist
- Verify the current fully diluted share count to assess the dilution impact of the 579,664 newly issued shares.
- Confirm the "Per Share Market Value" on August 13, 2026, to understand the valuation at which the cashless exercise was triggered.
- Review the Amended and Restated Share Purchase Agreement (dated August 29, 2025) and the side letter (dated September 24, 2025) for any remaining obligations or adjustment mechanisms related to GEM.
- Check subsequent filings for any impact on the Company's capitalization table or insider ownership percentages.